US Archives - Page 16 of 130 - European Medical Journal

Can Power Doppler Forecast Remission in Rheumatoid Arthritis?

Power Doppler ultrasound may provide important signals in predicting treatment response for patients with rheumatoid arthritis (RA), though its ability to forecast remission remains uncertain, according to a new systematic review.

New Review Finds Oral Probiotics Improve Acne Outcomes

Oral probiotics may offer therapeutic benefits for patients with acne, according to a new systematic review and meta-analysis of randomized trials.

Nanomedicine Breakthrough Improves Drug Delivery in Pediatric Brain Tumors

Pediatric central nervous system (CNS) tumors remain among the most fatal childhood cancers, largely because the blood-brain barrier (BBB) restricts effective therapeutic delivery and worsens clinical outcomes.

Targeted Therapies Offer Hope in Inflammatory Myopathies

Idiopathic inflammatory myopathies are complex immune-mediated disorders with multisystem involvement, and recent advances are reshaping both classification and treatment approaches.

Elexacaftor-Tezacaftor-Ivacaftor Cuts Liver Complications in Cystic Fibrosis

The availability of elexacaftor–tezacaftor–ivacaftor (ETI) has been associated with a marked reduction in cystic fibrosis liver disease (CFLD) progression, according to a nationwide analysis.

When Surgery Becomes Essential in Severe C. difficile

Severe Clostridioides difficile infection (CDI) can progress rapidly to organ failure and sepsis, and while most patients respond to antibiotic therapy, a minority face life-threatening disease that may require surgical intervention.

Real-World Data Show IL-1 Therapy Replacing Corticosteroids in Pericarditis

IL-1 pathway inhibition is increasingly replacing corticosteroids as the preferred second-line treatment for recurrent pericarditis, according to real-world registry data from the RESONANCE study.

Pancreatic Cancer Vaccine Linked to Extended Survival

A Phase I trial of a pancreatic cancer vaccine targeting mutant KRAS has demonstrated durable immune responses and promising survival outcomes in patients with minimal residual disease following standard treatment.

Lewy Body Dementia Hidden by Long-Term Schizophrenia

Lewy body dementia (LBD) can be especially difficult to identify in patients with a long history of psychiatric illness, where overlapping neuropsychiatric and motor symptoms may mask its emergence.

Kefir-Associated Yeast Linked to Patient Health Risks

Candida kefyr, a yeast species historically considered a rare human pathogen, is now being identified as an emerging cause of invasive fungal infections in solid organ transplant recipients, according to a recent case report and literature review.